Mingnan Chen
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Supramolecular Self-Assembly in Materials
- Silk-based biomaterials and applications
- Molecular Medicine top 5%
- Hydrogels: synthesis, properties, applications
Papers in
- Immunology 10
- Immunotherapy and Immune Responses 7
- Toxin Mechanisms and Immunotoxins 2
- T-cell and B-cell Immunology 2
- Oncology 8
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Ashutosh Chilkoti (4 shared papers)Jonathan R. McDaniel (4 shared papers)John Andrew MacKay (3 shared papers)Andrew J. Simnick (2 shared papers)Wenge Liu (2 shared papers)Marlène Bouvier (3 shared papers)Shuyun Dong (14 shared papers)Peng Zhao (10 shared papers)
- Journals
- Journal of Controlled Release (4 papers)Molecular Pharmaceutics (3 papers)Theranostics (3 papers)Biomaterials (2 papers)Nature Materials (1 paper)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Mingnan Chen
25 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 61
- Biomaterials 612
- Molecular Medicine 113
- Immunology 224
- Pharmaceutical Science 53
- Oncology 122
Countries citing papers authored by Mingnan Chen
This map shows the geographic impact of Mingnan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingnan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingnan Chen more than expected).
Fields of papers citing papers by Mingnan Chen
This network shows the impact of papers produced by Mingnan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingnan Chen. The network helps show where Mingnan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingnan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 533 | |
| 2 | 2007 | 145 | |
| 3 | 2014 | 128 | |
| 4 | 2010 | 86 | |
| 5 | 2019 | 69 | |
| 6 | 2015 | 52 | |
| 7 | 2014 | 46 | |
| 8 | 2016 | 43 | |
| 9 | 2016 | 36 | |
| 10 | 2008 | 34 | |
| 11 | 2017 | 29 | |
| 12 | 2017 | 28 | |
| 13 | 2021 | 27 | |
| 14 | 2018 | 13 | |
| 15 | 2002 | 12 | |
| 16 | 2016 | 11 | |
| 17 | 2023 | 8 | |
| 18 | 2017 | 7 | |
| 19 | 2011 | 6 | |
| 20 | 2017 | 6 |
About Mingnan Chen
Mingnan Chen is a scholar working on Immunology, Oncology, Biomaterials, Radiology, Nuclear Medicine and Imaging and Toxicology, having authored 26 papers that have together received 1.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Nanoparticle-Based Drug Delivery (5 papers), vaccines and immunoinformatics approaches (3 papers), Toxin Mechanisms and Immunotoxins (2 papers), T-cell and B-cell Immunology (2 papers), Bioactive Compounds and Antitumor Agents (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Biomaterials (612 citations), Molecular Medicine (113 citations), Immunology (224 citations), Pharmaceutical Science (53 citations) and Oncology (122 citations). Mingnan Chen has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Ashutosh Chilkoti, Jonathan R. McDaniel, John Andrew MacKay, Andrew J. Simnick, Wenge Liu, Marlène Bouvier, Shuyun Dong, Peng Zhao, Jin Zhang and Xiao He. Their work appears in journals such as Journal of Controlled Release, Molecular Pharmaceutics, Theranostics, Biomaterials and Nature Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.